Gonorrhea burden in sub-Saharan Africa remains stubbornly high: new meta-analysis reveals 3.2% general population prevalence
A comprehensive meta-analysis covering 1,604 prevalence measures documents that Neisseria gonorrhoeae affects 3.2% of the general population in sub-Saharan Africa,…
Editor's Top Picks
The Nigeria Methanol Crisis: Why Informal Alcohol Manufacturing Demands Urgent Regulatory Intervention
Nigeria's methanol poisoning outbreak, which claimed nearly fifty lives, reveals a catastrophic regulatory failure in informal alcohol manufacturing that demands…
Submit Your Paper to GMJ
First Lassa Fever Vaccine Shows Promise in Early Human Trial
First-in-human trial of dual rabies-Lassa fever vaccine shows promising safety and immune response results. The breakthrough could protect millions in…
When Colleagues Make Derogatory Comments About Patients: A Clinical Response Guide
New BMJ guidance provides healthcare professionals with a structured framework for addressing colleague's derogatory patient comments. Expert recommendations emphasize assessing…
WHO and BBC Launch Global Series on Animal-Human Health Connections
WOAH and BBC StoryWorks launch "Animals & Us," a multimedia series exploring critical animal-human health connections and One Health principles.…
Middle powers must unite on health data and AI to challenge tech dominance
Countries like Canada, Australia, and South Korea should unite to develop health AI systems that serve public interests rather than…
Kidney Drug Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
New clinical trial data show finerenone reduces kidney disease progression by 23% in non-diabetic patients. The drug could benefit millions…
Drinking Water Nitrate Linked to Higher Dementia Risk in Major 54,000-Person Study
Major study of 54,000+ adults reveals vegetable nitrates protect against dementia while drinking water and processed meat sources increase cognitive…
New Drug Target for Alzheimer’s Shows Promise in Preclinical Studies
Researchers identified a novel Alzheimer's mechanism and developed an experimental compound that slowed nerve cell loss in mouse models. The…
Dual Lassa Fever-Rabies Vaccine Shows Promise in First Human Trial
A novel dual vaccine targeting Lassa fever and rabies shows promising safety and immune response results in its first human…